This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Vifor Pharma バランスシートの健全性
財務の健全性 基準チェック /66
主要情報
13.6%
負債資本比率
CHF 540.20m
負債
| インタレスト・カバレッジ・レシオ | -377.5x |
| 現金 | CHF 993.60m |
| エクイティ | CHF 3.97b |
| 負債合計 | CHF 1.13b |
| 総資産 | CHF 5.10b |
財務の健全性に関する最新情報
Recent updates
財務状況分析
短期負債: GNHA.F's short term assets (CHF1.9B) exceed its short term liabilities (CHF981.3M).
長期負債: GNHA.F's short term assets (CHF1.9B) exceed its long term liabilities (CHF149.2M).
デット・ツー・エクイティの歴史と分析
負債レベル: GNHA.F has more cash than its total debt.
負債の削減: GNHA.F's debt to equity ratio has reduced from 86.5% to 13.6% over the past 5 years.
債務返済能力: GNHA.F's debt is well covered by operating cash flow (97.6%).
インタレストカバレッジ: GNHA.F earns more interest than it pays, so coverage of interest payments is not a concern.